All Pathways
Obstetrics & GynecologyManagement

Hyperemesis Gravidarum Management (ACOG 2018)

Hyperemesis Gravidarum Management (ACOG 2018): Nausea/Vomiting in Pregnancy → Initial Assessment → Severity Assessment → Mild NVP - Outpatient → Antieme...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Nausea/Vomiting in Pregnancy

    Assess severity and hydration status

    1. Action

      Initial Assessment

      Evaluate severity and exclude other causes

      • Vital signs - orthostatic hypotension?
      • Weight loss (>5% of prepregnancy weight = HG)
      • Ketonuria on urinalysis
      • Electrolytes, BMP
      • TSH (hyperthyroidism can cause vomiting)
      • Consider ultrasound (multiple gestation, molar?)
      1. Decision

        Severity Assessment

        NVP vs Hyperemesis Gravidarum

        • MILD NVP: Occasional vomiting, tolerating some PO
        • MODERATE: Daily vomiting, poor intake, mild dehydration
        • HYPEREMESIS: Weight loss >5%, ketonuria, severe dehydration
        1. Action

          Mild NVP - Outpatient

          First-line therapy

          • Dietary modifications:
          • - Small, frequent meals
          • - Avoid triggers (smells, spicy foods)
          • - Ginger 250mg QID or ginger tea
          • FIRST LINE: Vitamin B6 (pyridoxine) 10-25mg TID-QID
          • Add doxylamine 12.5mg TID-QID if needed (Diclegis/Bonjesta)
          1. Action

            Antiemetic Escalation

            Step-wise approach

            • STEP 1: B6 + doxylamine
            • STEP 2: Add ondansetron 4-8mg q8h
            • STEP 3: Add metoclopramide or promethazine
            • STEP 4: Methylprednisolone 16mg TID x 3 days, then taper
            • Avoid metoclopramide >12 weeks (tardive dyskinesia)
            • Ondansetron: theoretical cleft palate risk - discuss
            1. Decision

              Clinical Improvement?

              Tolerating PO, weight stable

              1. Outcome

                Discharge Criteria

                Transition to outpatient

                • Tolerating PO intake
                • No orthostatic hypotension
                • No ketonuria
                • Antiemetic regimen established
                • Follow-up in 1-2 weeks
                • Home IV if needed
                1. Outcome

                  Prognosis

                  Most cases resolve by 20 weeks

                  • Symptoms typically improve 14-20 weeks
                  • 10-20% have symptoms throughout pregnancy
                  • Reassure: HG does NOT harm fetus if treated
                  • Counsel on recurrence risk (15-20% next pregnancy)
              2. Action

                Refractory Cases

                When standard therapy fails

                • Enteral nutrition (NG/NJ tube)
                • TPN if enteral not tolerated (last resort)
                • PICC line for long-term IV access
                • Consider psychiatry consultation
                • Social work/support services
                • May require prolonged hospitalization
        2. Action

          Moderate - Consider IV Hydration

          Escalate therapy

          • IV fluids (NS or LR) - outpatient infusion or ED
          • Thiamine 100mg IV BEFORE dextrose
          • Add antiemetics if B6/doxylamine inadequate:
          • - Ondansetron 4-8mg PO/IV q8h
          • - Metoclopramide 5-10mg PO/IV q6-8h
          • - Promethazine 12.5-25mg PO/PR/IV q4-6h
        3. Action

          Hyperemesis Gravidarum - Admit

          Inpatient management

          • NPO initially
          • IV fluids with electrolyte repletion
          • THIAMINE 100mg IV BEFORE any dextrose (prevent Wernicke)
          • IV antiemetics scheduled (not PRN)
          • Correct electrolyte abnormalities
          • Daily weights, I/O monitoring
          1. Warning

            ⚠️ THIAMINE Before Dextrose

            Prevent Wernicke encephalopathy

            • Give thiamine 100mg IV BEFORE any glucose/dextrose
            • Dextrose can precipitate Wernicke in thiamine-depleted patients
            • Signs: confusion, ataxia, ophthalmoplegia
      2. Decision

        Consider Alternative Diagnoses

        If atypical presentation

        • Onset after 10 weeks - consider other causes
        • Hyperthyroidism
        • Molar pregnancy
        • GI disorders (gastroparesis, cholecystitis)
        • UTI
        • Appendicitis

Guideline Source

ACOG Practice Bulletin No. 189: Nausea and Vomiting of Pregnancy

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Diagnosis of exclusion - rule out other causes
  • Thiamine deficiency can cause Wernicke encephalopathy
  • Some patients require prolonged hospitalization or TPN

Applicable Regions

USEUGlobal
Version 1Next review: 2027-01-01

Frequently Asked Questions

What is the Hyperemesis Gravidarum Management (ACOG 2018)?

The Hyperemesis Gravidarum Management (ACOG 2018) is a management clinical algorithm for Obstetrics & Gynecology. It provides a structured decision tree to guide clinical decision-making, based on ACOG Practice Bulletin No. 189: Nausea and Vomiting of Pregnancy.

What guideline is the Hyperemesis Gravidarum Management (ACOG 2018) based on?

This algorithm is based on ACOG Practice Bulletin No. 189: Nausea and Vomiting of Pregnancy (DOI: 10.1097/AOG.0000000000002456).

What are the limitations of the Hyperemesis Gravidarum Management (ACOG 2018)?

Known limitations include: Diagnosis of exclusion - rule out other causes; Thiamine deficiency can cause Wernicke encephalopathy; Some patients require prolonged hospitalization or TPN. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Hyperemesis Gravidarum Management (ACOG 2018) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free